Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19471888 | 1.00 | LMNA (0.34) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL28954263 | 0.85 | LMNA (0.33) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9160314 | 0.85 | TSHR (0.34) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9160338 | 0.85 | TSHR (0.34) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL5740275 | 0.82 | MAPK1 (0.35) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9398163 | 0.81 | ACHE (0.34) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9398153 | 0.81 | ACHE (0.34) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL10945779 | 0.81 | LMNA (0.38) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9396127 | 0.81 | CNR2 (0.37) | LMNAMAPK1HTTCNR2CNR1 | |
| SCHEMBL9396123 | 0.81 | CNR2 (0.37) | LMNAMAPK1HTTCNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2957591-B1 | REMEDIATION OF YELLOWING IN A COATING FORMULATION CONTAINING A SORBATE ESTER OR A SORBAMIDE COALESCENT | ROHM & HAAS (US) | 2018-07-11 | — | — | EP | disclosed |
| US-9828510-B2 | Sorbic acid ester containing coatings composition | ROHM AND HAAS COMPANY (US) | 2017-11-28 | — | — | US | disclosed |
| US-9828510-B2 | Sorbic acid ester containing coatings composition | ROHM AND HAAS COMPANY (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170305831-A1 | PREPARATION OF A SORBATE ESTER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-26 | — | — | US | disclosed |
| US-9714359-B2 | Remediation of yellowing in a coatings formulation containing a sorbate ester or a sorbamide coalescent | ROHM AND HAAS COMPANY (US) | 2017-07-25 | — | — | US | disclosed |
| US-9714359-B2 | Remediation of yellowing in a coatings formulation containing a sorbate ester or a sorbamide coalescent | ROHM AND HAAS COMPANY (US) | 2017-07-25 | — | — | US | disclosed |
| US-20170037266-A1 | SORBATE ESTER OR SORBAMIDE COALESCENT IN A COATINGS FORMULATION | THE DOW CHEMICAL COMPANY (US) | 2017-02-09 | — | — | US | disclosed |
| US-20170037266-A1 | SORBATE ESTER OR SORBAMIDE COALESCENT IN A COATINGS FORMULATION | THE DOW CHEMICAL COMPANY (US) | 2017-02-09 | — | — | US | disclosed |
| US-20160272825-A1 | SORBIC ACID ESTER CONTAINING COATINGS COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160272825-A1 | SORBIC ACID ESTER CONTAINING COATINGS COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-22 | — | — | US | disclosed |
| EP-3070129-A1 | SORBIC ACID ESTER CONTAINING COATINGS COMPOSITION | Dow Global Technologies LLC (US) | 2016-09-21 | — | — | EP | disclosed |
| EP-3029116-A1 | SORBIC ACID ESTER COMPOSITION | Dow Global Technologies LLC (US) | 2016-06-08 | — | — | EP | disclosed |
| US-20160152856-A1 | SORBIC ACID ESTER COMPOSITION | ROHM & HAAS (US) | 2016-06-02 | — | — | US | disclosed |
| US-20160152856-A1 | SORBIC ACID ESTER COMPOSITION | ROHM & HAAS (US) | 2016-06-02 | — | — | US | disclosed |
| EP-2957591-A1 | REMEDIATION OF YELLOWING IN A COATING FORMULATION CONTAINING A SORBATE ESTER OR A SORBAMIDE COALESCENT | Rohm and Haas Company (US) | 2015-12-23 | — | — | EP | disclosed |
| US-20150361290-A1 | REMEDIATION OF YELLOWING IN A COATINGS FORMULATION CONTAINING A SORBATE ESTER OR A SORBAMIDE COALESCENT | ROHM AND HAAS COMPANY | 2015-12-17 | — | — | US | disclosed |
| US-20150361290-A1 | REMEDIATION OF YELLOWING IN A COATINGS FORMULATION CONTAINING A SORBATE ESTER OR A SORBAMIDE COALESCENT | ROHM AND HAAS COMPANY | 2015-12-17 | — | — | US | disclosed |
| WO-2015157929-A1 | SORBATE ESTER OR SORBAMIDE COALESCENT IN COATINGS FORMULATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305831-A1 | PREPARATION OF A SORBATE ESTER | HAO2, SORBS1, HAO1 | LMNA 2010/4885MAPK1 1854/4885HTT 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.